Raj Patil

About Raj Patil

At OKYO Pharma, my role as Chief Scientific Officer centers on crafting a scientific vision to cultivate an innovative pipeline targeting ocular disorders, while ensuring alignment with our corporate mission. Our team\'s success in advancing lead drug candidates through non-clinical and clinical stages is a testament to our strategic partnerships in academia and with industry specialists such as CROs and CDMOs.The journey involves providing scientific leadership and interfacing with key opinion leaders to promote OKYO\'s groundbreaking work. My expertise in drug discovery and life sciences has been honed by strategically managing OKYO\'s R&D and contributing to the non-clinical and clinical drug development. This has culminated in a robust approach to tackling sight-threatening eye diseases, leveraging our collective expertise in pharmaceuticals to achieve rapid clinical translation and path to drug registration.

Experience

1. Chief Scientific Officer

   Okyo Pharma

   Mar 2021 — Present · New York, NY, US

   Responsible for developing OKYO’s scientific strategy to build a diverse pipeline of novel products targeting ocular disorders and oversee non-clinical and clinical development of lead drug candidates by building partnerships and collaborations with academia and various CROs and CDMOs in order to achieve rapid clinical translation, with a path to registration.Provide visionary and scientific leadership, aligning scientific expectations with the corporate vision and interacting with academic KOLs, investigators and other clinical stakeholders.Represent OKYO and its programs to internal and external audiences, including the Board of Directors, SAB, investment groups, medical and regulatory communities, as well as pharmaceutical/biotechnology industry collaborators/partners.

Education

• Savitribai Phule Pune University

  Doctor of Philosophy - PhD, Biochemistry

• University of Michigan

  Postdoctoral Scholar, Biochemistry and Molecular Biology

Skills

• Immunology
• Assay Development
• Drug Discovery
• CRO
• Drug Delivery
• Cross-Functional Team Leadership
• Lead Change
• In Vitro
• Therapeutic Areas
• Pharmacology
• Cell Culture
• Team Building
• Business Development
• In Vivo
• Pharmacokinetics
• Clinical Development
• Genetics
• Team Leadership
• Cell Biology
• Strategic Planning
• Communication
• Cell
• Target Identification
• Lifesciences
• Technology Transfer
• Biomarkers
• Life Sciences
• Toxicology
• Business Strategy
• High Throughput Screening
• Physiology
• Ophthalmology
• Biotechnology
• Protein Purification
• Business Analysis
• Clinical Trials
• Elisa
• Pharmaceutical Industry
• Neurodegeneration
• Molecular Biology